Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="van der Heijde, Désirée" or (type any "bookEditor issueEditor" and editor="van der Heijde...

Add to list
- Miscellaneous
Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature

Désirée van der Heijde, Anna Molto, Sofia Ramiro, Jürgen Braun, Maxime Dougados, Floris A van Gaalen, Lianne S Gensler, Robert D Inman, Robert B M Landewé, Helena Marzo-Ortega, et al.

(2023) Annals of the Rheumatic Diseases. p.ard-2023
Add to list
- Journal Article
- A1
- open access
Response to : 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial' by Cai and Peng response

Anna Molto, Desiree van der Heijde, Filip Van den Bosch (UGent) and Maxime Dougados

(2023) ANNALS OF THE RHEUMATIC DISEASES. 82(7).
Add to list
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2) : a randomised, double-blind, placebo-controlled, phase 3 trial

Atul Deodhar, Filip Van den Bosch (UGent) , Denis Poddubnyy, Walter P Maksymowych, Désirée van der Heijde, Tae-Hwan Kim, Mitsumasa Kishimoto, Ricardo Blanco, Yuanyuan Duan, Yihan Li, et al.

(2022) LANCET. 400(10349). p.369-379
Add to list
Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis

Uta Kiltz, Annelies Boonen, Désirée van der Heijde, Wilson Bautista-Molano, Ruben Burgos Vargas, Praveena Chiowchanwisawakit, Bassel El-Zorkany, Inna Gaydukova, Pal Geher, Laure Gossec, et al.

(2022) RHEUMATOLOGY. 61(5). p.2054-2062
Add to list
- Journal Article
- A1
- open access
Upadacitinib in active ankylosing spondylitis : results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension

Desiree van der Heijde, Atul Deodhar, Walter P. Maksymowych, Joachim Sieper, Filip Van den Bosch (UGent) , Tae-Hwan Kim, Mitsumasa Kishimoto, Andrew J. Ostor, Bernard Combe, Yunxia Sui, et al.

(2022) RMD OPEN. 8(2).
Add to list
- Journal Article
- A1
- open access
Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis : a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR

Walter P. Maksymowych, Pascal Claudepierre, Manouk de Hooge (UGent) , Robert G. Lambert, Robert Landewé, Anna Molto, Désirée van der Heijde, Jack F. Bukowski, Heather Jones, Ron Pedersen, et al.

(2021) ARTHRITIS RESEARCH & THERAPY. 23(1).
Add to list
- Journal Article
- A1
- open access
Core outcome measurement instrument selection for physical function in hand osteoarthritis using the OMERACT Filter 2.1 process

Féline P.B. Kroon, Désirée van der Heijde, Lara J. Maxwell, Dorcas E. Beaton, Abishek Abishek, Francis Berenbaum, Francisco J. Blanco, Philip G. Conaghan, Krysia Dziedzic, Catherine L. Hill, et al.

(2021) SEMINARS IN ARTHRITIS AND RHEUMATISM. 51(6). p.1311-1319
Add to list
- Journal Article
- A1
- open access
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial

Anna Molto, Clementina López-Medina, Filip Van den Bosch (UGent) , Annelies Boonen, Casper Webers, Emanuelle Dernis, Floris A van Gaalen, Martin Soubrier, Pascal Claudepierre, Athan Baillet, et al.

(2021) ANNALS OF THE RHEUMATIC DISEASES. 80(11). p.1436-1444
Add to list
Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies

Uta Kiltz, James Cheng-Chung Wei, Desiree van der Heijde, Filip Van den Bosch (UGent) , Jessica A. Walsh, Annelies Boonen, Lianne S. Gensler, Theresa Hunter, Hilde Carlier, Yan Dong, et al.

(2021) JOURNAL OF RHEUMATOLOGY. 48(2). p.188-197
Add to list
Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility

Walter P. Maksymowych, Robert G. Lambert, Xenofon Baraliakos, Ulrich Weber, Pedro M. Machado, Susanne J. Pedersen, Manouk de Hooge (UGent) , Joachim Sieper, Stephanie Wichuk, Denis Poddubnyy, et al.

(2021) RHEUMATOLOGY. 60(10). p.4778-4789

Academic Bibliography

Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature

Response to : 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial' by Cai and Peng response

Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2) : a randomised, double-blind, placebo-controlled, phase 3 trial

Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis

Upadacitinib in active ankylosing spondylitis : results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension

Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis : a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR

Core outcome measurement instrument selection for physical function in hand osteoarthritis using the OMERACT Filter 2.1 process

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial

Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies

Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility

Contents

Support

Contact